Health Plan News logo

Schering-Plough to Acquire Organon BioSciences

Schering-Plough Corporation (NYSE:SGP) has recently announced that its Board of Directors has approved a transaction under which Schering-Plough will acquire Organon BioSciences N.V., the human and animal health care businesses of Akzo Nobel N.V., for approximately €11 billion in cash ($14.4 billion based on closing exchange rate on March 9, ...

March 2nd 2010
Tags: Healthcare Plan News Comments Off

HealthPass Now Offering UnitedHealthcare’s Oxford Health Benefit Plans

HealthPass, a partnership between New York City, the New York Business Group on Health, and the health insurance industry, is now offering five of UnitedHealthcare's Oxford health insurance plans to employers. To qualify, the employers must have two to 50 eligible employees and be based in New York City or ...
March 2nd 2010
Tags: Healthcare Plan News Comments Off

Verizon Wireless’ Mobile Healthcare Solutions Let Hospitals and Clinics Streamline Communications and Access Critical Data

BASKING RIDGE, N.J., and ATLANTA, March 2 /PRNewswire/ -- Healthcare organizations ranging from large city hospitals to rural community health clinics can count on Verizon Wireless to deliver customized wireless solutions that allow caregivers the ability to utilize resources that enhance the patient experience. Representatives from Verizon Wireless, operator of ...
March 2nd 2010
Tags: Healthcare Plan News Comments Off

Enanta Nominates EDP-239 as Lead Development Candidate for NS5A HCV Inhibitor Program

WATERTOWN, Mass., March 2 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing. "Our NS5A inhibitor program ...
March 2nd 2010
Tags: Healthcare Plan News Comments Off

Abbott and Enanta Announce Advancement of Hepatitis C Collaboration

ABBOTT PARK, Ill. and WATERTOWN, Mass., March 2 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. The trial will evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration, and ...
March 2nd 2010
Tags: Healthcare Plan News Comments Off

HealthPass Now Offering UnitedHealthcare’s Oxford Health Benefit Plans to New York-Area Small Businesses

NEW YORK, March 2 /PRNewswire/ -- A new relationship between UnitedHealthcare and HealthPass gives New York-area small businesses more health benefit plan options. HealthPass, a partnership between the New York Business Group on Health, New York City and the health insurance industry, is offering five of UnitedHealthcare's Oxford health insurance plans ...

Search

The archives run deep. Feel free to search older content using topic keywords.

Browse by Category